Magneto/optical annexin V, a multimodal protein

被引:145
作者
Schellenberger, EA
Sosnovik, D
Weissleder, R
Josephson, L
机构
[1] Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA 02129 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
D O I
10.1021/bc049905i
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Multimodal proteins, or proteins labeled with both fluorescent and magnetic reporter groups, can be used in a wide range of applications including FACS or fluorescence microscopy, MRI and or near-infrared based optical imaging, or to fractionate cells by magnetic cell sorting. A problem with multimodal proteins, however, is the need to maximize bioactivity, often achieved by minimizing the number of modification points of the protein, while attaching fluorescent and magnetic labels. Here we describe the synthesis of a magneto/optical form of annexin V, achieved by reacting the amino-CLIO nanoparticle with Cy5.5 and SPDP, to produce a fluorescent, sulfhydryl reactive nanoparticle. A single reactive sulfhydryl group was added to annexin V by reaction with SATA that preserved the protein's ability to bind apoptotic Jurkat T cells. Reacting SATAylated annexin V with an SPDP activated nanoparticle yielded Anx-CLIO-Cy5.5, a magneto/optical form of annexin V. The binding of Anx-CLIO-Cy5.5 was specific for apoptotic Jurkat T cells and had an EC50 of 3.66 nM. This was comparable to the strength of the interaction of unmodified annexin V with apoptotic cells, measured as the displacement of FITC-annexin by annexin V (2.4 nM). Our conjugation strategy preserves the strength of the interaction between annexin V and apoptotic cells, while yielding a probe, Anx-CLIO-Cy5.5, that is readily detectable by standard MR imaging or NIRF optical methods.
引用
收藏
页码:1062 / 1067
页数:6
相关论文
共 42 条
[1]  
Blankenberg FG, 1999, J NUCL MED, V40, P184
[2]   CELL-DEATH BY APOPTOSIS AND ITS PROTECTIVE ROLE AGAINST DISEASE [J].
BURSCH, W ;
OBERHAMMER, F ;
SCHULTEHERMANN, R .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (06) :245-251
[3]   HUMAN PLACENTAL ANTICOAGULANT PROTEIN - ISOLATION AND CHARACTERIZATION [J].
FUNAKOSHI, T ;
HEIMARK, RL ;
HENDRICKSON, LE ;
MCMULLEN, BA ;
FUJIKAWA, K .
BIOCHEMISTRY, 1987, 26 (17) :5572-5578
[4]  
Gorczyca W, 1998, METH MOL B, V91, P217
[5]  
Green DR, 2000, METHOD ENZYMOL, V322, P15
[6]   Biomedical applications of maghemite ferrofluid [J].
Halbreich, A ;
Roger, J ;
Pons, JN ;
Geldwerth, D ;
Da Silva, MF ;
Roudier, M ;
Bacri, JC .
BIOCHIMIE, 1998, 80 (5-6) :379-390
[7]   Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death [J].
Hammill, AK ;
Uhr, JW ;
Scheuermann, RH .
EXPERIMENTAL CELL RESEARCH, 1999, 251 (01) :16-21
[8]   Fluorescently detectable magnetic resonance imaging agents [J].
Hüber, MM ;
Staubli, AB ;
Kustedjo, K ;
Gray, MHB ;
Shih, J ;
Fraser, SE ;
Jacobs, RE ;
Meade, TJ .
BIOCONJUGATE CHEMISTRY, 1998, 9 (02) :242-249
[9]  
Josephson L, 2001, ANGEW CHEM INT EDIT, V40, P3204, DOI 10.1002/1521-3773(20010903)40:17<3204::AID-ANIE3204>3.0.CO
[10]  
2-H